The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeGrowth
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BST | 46.26 | 0.59 | +1.29% |
| BlackRock Science and Technology Trust | |||
| JULB | 27.67 | 0.15 | +0.54% |
| Aptus July Buffer ETF | |||
| DYLD | 22.26 | N/A | -0.02% |
| LeaderShares® Dynamic Yield ETF | |||
| FDEV | 37.15 | -0.31 | -0.83% |
| Fidelity International Multifactor ETF | |||
| THNR | 25.40 | -0.47 | -1.81% |
| Amplify Weight Loss Drug & Treatment ETF | |||
A.I.dvisor indicates that over the last year, PTSGX has been closely correlated with VIGAX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTSGX jumps, then VIGAX could also see price increases.
| Ticker / NAME | Correlation To PTSGX | 1D Price Change % | ||
|---|---|---|---|---|
| PTSGX | 100% | +0.67% | ||
| VIGAX - PTSGX | 92% Closely correlated | +1.15% | ||
| VIGIX - PTSGX | 92% Closely correlated | +1.15% | ||
| GFACX - PTSGX | 91% Closely correlated | +1.17% | ||
| RGACX - PTSGX | 89% Closely correlated | +1.16% | ||
| RGAEX - PTSGX | 88% Closely correlated | +1.16% | ||
More | ||||